Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Chemspec International Ltd
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000950123-11-083286 (34 Act) Size: KB |
Sep-08-2011 | 111079978 |
15-12B | Document | Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001193125-11-234830 (34 Act) Size: KB |
Aug-29-2011 | 111061475 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-11-230481 (34 Act) Size: KB |
Aug-24-2011 | 111052769 |
25-NSE | Document | Acc-no: 0000876661-11-000354 (34 Act) Size: KB | Aug-19-2011 | 111046371 |
SC 13D/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001193125-11-227080 (34 Act) Size: KB |
Aug-19-2011 | 111046059 |
SC 13E3/A | Document | Amendment to Schedule filed to report going private transactions Acc-no: 0001193125-11-227069 (34 Act) Size: KB |
Aug-19-2011 | 111046050 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-11-227062 (34 Act) Size: KB |
Aug-19-2011 | 111046046 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-11-227007 (33 Act) Size: KB |
Aug-19-2011 | 111046012 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-11-222677 (34 Act) Size: KB |
Aug-15-2011 | 111034659 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-11-185626 (34 Act) Size: KB |
Jul-11-2011 | 11960846 |
SC 13E3/A | Document | Amendment to Schedule filed to report going private transactions Acc-no: 0001193125-11-185384 (34 Act) Size: KB |
Jul-11-2011 | 11960674 |
SC 13E3/A | Document | Amendment to Schedule filed to report going private transactions Acc-no: 0001193125-11-171233 (34 Act) Size: KB |
Jun-23-2011 | 11926669 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001193125-11-171224 ( Act) Size: KB |
Jun-23-2011 | |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-11-169266 (34 Act) Size: KB |
Jun-21-2011 | 11922356 |
20-F | Document | Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001193125-11-168259 (34 Act) Size: KB |
Jun-20-2011 | 11920023 |
UPLOAD | Document | Acc-no: 0000000000-11-035059 ( Act) Size: KB | Jun-07-2011 | |
SC 13E3/A | Document | Amendment to Schedule filed to report going private transactions Acc-no: 0001193125-11-150931 (34 Act) Size: KB |
May-26-2011 | 11872545 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001193125-11-150924 ( Act) Size: KB |
May-26-2011 | |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-11-150905 (34 Act) Size: KB |
May-26-2011 | 11872534 |
UPLOAD | Document | Acc-no: 0000000000-11-030124 ( Act) Size: KB | May-13-2011 |
Recent 20 filings. View all Chemspec International Ltd filings
Huge help thank you for your help .. y'all make it so much easier
young lad who new his job ansered questions and new what was best for me.
Thanks I look forward to using the product to improve my skin tone
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by